Squamous cell carcinoma development in Fanconi anemia patients who underwent hematopoietic stem cell transplantation

Basit Öğe Kaydı
dc.authorid0000-0001-8489-7449
dc.authorid0000-0002-7424-8688
dc.contributor.authorAnak, Sema
dc.contributor.authorYalman, Nevin
dc.contributor.authorBilgen, Hülya
dc.contributor.authorSepet, Elif
dc.contributor.authorDeviren, Ayhan
dc.contributor.authorGürtekin, Başak
dc.contributor.authorTunca, Fatih
dc.contributor.authorBaşaran, Bora
dc.date.accessioned2020-07-29T09:28:18Z
dc.date.available2020-07-29T09:28:18Z
dc.date.issued2020
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
dc.description.abstractWe examined SCC development of 24 FA patients, who received HSCT from HLA-matched relatives. In our BMT center, we applied low-dose CY + LFI + ATG (n:13) as conditioning regimen for FA patients between 1992 and 1999, and CY + BU + ATG (n:11) between 1999 and 2002. The aim of this study was to investigate SCC development after HSCT and examine features of the follow-up patients. The 10-year overall survival (OS) of the group with LFI + regimen was 43%, whereas the group without LFI regimen was 60%. There was a statistically significant relationship between infections (viral/bacterial) and overall survival (Fisher's Exact test P < .001). Five out of 13 long-term (>1 year) surviving patients developed SCC in the HNSCC (n:4) and esophagus (n:2) region (a patient with oral SCC developed a second primary esophageal SCC). The SCC rate in our FA patients was 38%, four of the SCC patients were transplanted with irradiation used conditioning regimens, three of them had acuteGvHD (Grade II-III), only one developed chronic GvHD. The interval between HSCT and SCC diagnosis was median 13 (range 6-18) years, the age for the development of cancer was median 21 (range 15-32) years. Survival after SCC was low, median 6 months (range 6-12), due to delayed SCC diagnosis, tumor progression under therapy and treatment-related toxicities of the usually reduced RT and/or CT.
dc.identifier.citationAnak, S., Yalman, N., Bilgen, H., Sepet, E., Deviren, A., Gürtekin, B. ... Başaran, B. (2020). Squamous cell carcinoma development in Fanconi anemia patients who underwent hematopoietic stem cell transplantation. Pediatric Transplantation, 24(4). https://dx.doi.org/10.1111/petr.13706
dc.identifier.doi10.1111/petr.13706
dc.identifier.issn1397-3142
dc.identifier.issn1399-3046
dc.identifier.issue4
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://dx.doi.org/10.1111/petr.13706
dc.identifier.urihttps://hdl.handle.net/20.500.12511/5640
dc.identifier.volume24
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofPediatric Transplantationen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectFanconi Anemia
dc.subjectGvHD
dc.subjectHematopoietic Stem Cell Transplantation
dc.subjectSquamous Cell Carcinoma
dc.titleSquamous cell carcinoma development in Fanconi anemia patients who underwent hematopoietic stem cell transplantation
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Anak, Sema-2020.pdf
Boyut:
266 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu